First Wave BioPharma Provides Update On IND Filing For Phase 2 Trial Of Enhanced Microgranule Formulation Of Adrulipase For Exocrine Pancreatic Insufficiency
First Wave BioPharma, Inc. (NASDAQ:FWBI) ("First Wave BioPharma" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies
ConocoPhillips In Talks To Sell Venezuelan Oil In U.S. To Recover Billions In Debt
-Wall Street Journal
Washington Federal Q1 EPS $1.16 Beats $1.09 Estimate, Sales $182.80M Beat $179.20M Estimate
Washington Federal (NASDAQ:WAFD) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $1.09 by 6.42 percent. This is a 63.38 percent increase over earnings of $0.71 per share from